Skip to main content
SpringerLink
Log in

The Role of Eosinophils in Atopic Eczema

  • Chapter
Handbook of Atopic Eczema

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ (1998) Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 252:418–425

    Article  CAS  PubMed  Google Scholar 

  2. Straumann A, Simon HU (2004) The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 59:15–25

    Article  CAS  PubMed  Google Scholar 

  3. Mihm MC, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305–312

    PubMed  Google Scholar 

  4. Steigleder GK, Inderwisch R (1975) Eosinophilic leucocytes in the skin lesions of psoriasis and atopic dermatitis. Arch Dermatol Res 254:253–255

    CAS  PubMed  Google Scholar 

  5. Braun-Falco O, Burg G (1974) Celluläres infiltrat und Capillaren bei Neurodermitis diffusa. Arch Derm Forsch 249:113–124

    Article  CAS  Google Scholar 

  6. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A (2001) Tissue eosinophilia in acute and chronic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 145:720–29

    Article  CAS  PubMed  Google Scholar 

  7. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS (1999) Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103:1103–1111. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS (1999) Roles of Th1 and Th2 cytokines in amurine model of allergic dermatitis. J Clin Invest 103:1103–1111

    CAS  PubMed  Google Scholar 

  8. Kagi MK, Joller-Jemelka H, Wüthrich B (1992) Correlation of eosinophils, eosinophilic cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 185:88–92

    CAS  PubMed  Google Scholar 

  9. Uehara M, Izukura R, Sawai T (1990) Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 15:264–266

    CAS  PubMed  Google Scholar 

  10. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, Kreyden O, Disch R, Wüthrich B, Blaser K, Simon H-U (1999) T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 113:628–634

    Article  CAS  PubMed  Google Scholar 

  11. Sur S, Glitz DG, Kita H, Kujawa SM, Peterson EA, Weiler DA, Kephart GM, Wagner JM, George TJ, Gleich GJ, Leiferman KM (1998) Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J Leukoc Biol 63:715–722

    CAS  PubMed  Google Scholar 

  12. Czech W, Krutmann J, Schopf E, Kapp A (1992) Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126:351–355

    CAS  PubMed  Google Scholar 

  13. Halmerbauer G, Frischer T, Koller DY (1997) Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood. Allergy 52:765–769

    CAS  PubMed  Google Scholar 

  14. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y (2001) Serum eosinophil-derived neurotoxin may reflect more strongly disease activity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 26:79–82

    Article  CAS  PubMed  Google Scholar 

  15. Caproni M, Agata AD, Cappelli G, Fabbri P (1996) Modulation of serum eosinophilic cationic protein levels by cyclosporin in severe atopic dermatitis. Br J Derm 135:336

    CAS  Google Scholar 

  16. Stevens SR, Hanifin JM, Hamilton T, Tofte SJ, Cooper KD (1998) Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 134:799–804

    Article  CAS  PubMed  Google Scholar 

  17. Wakugawa M, Nakagawa H, Yamada N, Tamaki K (1996) Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects. Int Arch Allergy Immunol 111:S5–11

    Google Scholar 

  18. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schopf E (1992) High-doseUV A1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26:225–230

    CAS  PubMed  Google Scholar 

  19. Kim TY, Park HJ, Kim CW (1997) Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases. J Dermatol Sci. 15:89–94

    CAS  PubMed  Google Scholar 

  20. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM (1994) Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late phase reaction. J Allergy Clin Immunol 94:120–128

    Article  CAS  PubMed  Google Scholar 

  21. Wassom DL, Loegering DA, Solley GO, Moore SB, Schooley RT, Fauci AS, Gleich GJ (1981) Elevated serumlevels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 67:651–661

    CAS  PubMed  Google Scholar 

  22. Breuer K, Kapp A, Werfel T (2001) Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis in the adult age. Allergy 56:780–784

    CAS  PubMed  Google Scholar 

  23. Tischendorf FW, Brattig NW, Lintzel M, Buttner DW, Burchard GD, Bork K, Muller M (2000) Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Trop Med Int Health 5:898–905

    Article  CAS  PubMed  Google Scholar 

  24. Prussin C, Metcalfe DD (2003) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 111:S486–494

    Article  CAS  PubMed  Google Scholar 

  25. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ (1985) Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 313:282–285

    CAS  PubMed  Google Scholar 

  26. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ (1990) Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous lete phase reaction. Lab Invest 62:579–589

    CAS  PubMed  Google Scholar 

  27. Cheng JF, Ott NL, Peterson EA, George TJ, Hunkee MJ, Gleich GJ, Leiferman KM (1997) Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 99:683–692

    Article  CAS  PubMed  Google Scholar 

  28. Leiferman KM (2001) A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 45:S21–24

    Article  CAS  PubMed  Google Scholar 

  29. Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, Ackerman SJ, Gleich GJ, Bienenstock J (1985) Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 66:312–318

    CAS  PubMed  Google Scholar 

  30. Linden M, Svenson C, Andersson M, Greiff L, Andersson E, Denburg JA, Persson CG (1999) Circulating eosinophil/ basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy 54:212–219

    Article  CAS  PubMed  Google Scholar 

  31. Cyr MM, Denburg JA (2001) Systemic aspects of allergic diseases: the role of the bonemarrow. Curr Opin Immunol 13:727–732

    Article  CAS  PubMed  Google Scholar 

  32. Dent LA, Strath M, Mellor AL, Sanderson CJ (1990) Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172:1425–1431

    Article  CAS  PubMed  Google Scholar 

  33. Foster P, Hogan P, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin-5 deficiency abolishes eosinophilia, airway hyperreactivity and lung damage in a mouse asthma model. J Exp Med 183:195–201

    Article  CAS  PubMed  Google Scholar 

  34. Nashinakamura R, Miyajima A, Mee PJ, Tybulewicz VLJ, Murray R (1996) Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88:2458–2464

    Google Scholar 

  35. Saito H, Howie K, Wattie J, Denburg A, Ellis R, Inman MD, Denburg J (2001) Allergen-induced murine upper airway inflammation: local and systemic in murine experimental allergic rhinitis. Immunology 104:226–234

    Article  CAS  PubMed  Google Scholar 

  36. Palframan RT, Collins PD, Severs NJ, Rothery S, Williams TJ, Rankin SM (1998) Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin-5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 188:1621–1632

    Article  CAS  PubMed  Google Scholar 

  37. Palframan RT, Collins PD, Williams TJ, Rankin SM (1998) Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91:2240–2248

    CAS  PubMed  Google Scholar 

  38. Broide D, Sriramarao P (2001) Eosinophil trafficking to sites of allergic inflammation. Immunological Reviews 179:163–172

    Article  CAS  PubMed  Google Scholar 

  39. Bochner BS, Charlesworth EN, Lichtenstein LM (1990) Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 86:830–839

    CAS  PubMed  Google Scholar 

  40. Mullarkey M, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA (1994) Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol 52:2033–2041

    Google Scholar 

  41. Wakita H, Sakamoto T, Tokura Y, Takigawa M (1993) E-selectin and vascular adhesion molecule 1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 21:33–39

    Google Scholar 

  42. Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer R, Zacchi T, Harlan JM, Patriarca P (1991) Mechanisms of eosinophil adherence to cultured vascular endothelial cells. J Clin Invest 88:20–26

    CAS  PubMed  Google Scholar 

  43. Moser R, Fehr J, Bruijnzeel LB (1992) IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 149:1432–1438

    CAS  PubMed  Google Scholar 

  44. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA, McIntyre BW, Bochner BS (1992) IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086–1092

    CAS  PubMed  Google Scholar 

  45. Schnyder B, Lugli S, Feng N, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, Moser R (1996) IL-4 and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular adhesion molecule-1 induction in the absence of the common γ chain. Blood 87:4286–4295

    CAS  PubMed  Google Scholar 

  46. Elsner J, Kapp A (1999) Regulation and modulation of eosinophil effector functions. Allergy 54:15–26

    CAS  PubMed  Google Scholar 

  47. DiScipio R, Daffern P, Jagels MA, Broide DH, Sriramarao P (1999) C3a and C5a mediate the rapid activation dependent conversion of rolling eosinophils to firmly adherent eosinophils in vivo. J Immunol 162:1127–1136

    CAS  PubMed  Google Scholar 

  48. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T-helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255–262

    Article  CAS  PubMed  Google Scholar 

  49. Tager AM, Dufour JH, Goodarzi K, Bercury SD, von Adrian UH, Luster AD (2000) BLTR mediates leukotriene (4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in amurinemodel of peritonitis. J Exp Med 192:439–446

    Article  CAS  PubMed  Google Scholar 

  50. Bandeira-Melo C, Bozza PT, Dias BL, Cordeiro RS, Jose PJ, Martins MA, Serhan CN (2000) Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol 164:2267–2271

    CAS  PubMed  Google Scholar 

  51. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schröder JM (1998) IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 160:60–68

    CAS  PubMed  Google Scholar 

  52. Dombrovicz D, Capron M (2001) Eosinophils, allergy and parasites. Curr Opin Immunol 13:716–720

    Google Scholar 

  53. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 85:785–790

    Google Scholar 

  54. Ying S, Taborda-Barate L, Meng Q, Humbert M, Kay MB (1995) The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 181:2153–2159

    Article  CAS  PubMed  Google Scholar 

  55. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proud-foot A, Martinez-A C, Dorf M, Bkerke T, Coyle AJ, Gutierrez-Ramos JC (1998) The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188:157–167

    Article  CAS  PubMed  Google Scholar 

  56. Sallusto F, Mackay CR, Lanzavechia A (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593–620

    Article  CAS  PubMed  Google Scholar 

  57. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:2349–2354

    Article  Google Scholar 

  58. Homey B, Zlotnik A (1999) Chemokines in allergy. Curr Opin Immunol 11:626–634

    Article  CAS  PubMed  Google Scholar 

  59. Yawalkar N, Uguccioni M, Schärer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M (1999) Enhanced expression of eotaxin and CCR-3 in atopic dermatitis. J Invest Dermatol 113:43–48

    Article  CAS  PubMed  Google Scholar 

  60. Weilie M, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, Friend DS, Oettgen HC, Gerard C, Geha RS (2002) CCR-3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109:621–628

    Google Scholar 

  61. Masumoto A, Hemler ME (1993) Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS-1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 268:228–234

    CAS  PubMed  Google Scholar 

  62. Gleich GJ (2000) Mechanisms of eosinophil associated inflammation. J Allergy Clin Immunol 105:651–663

    Article  CAS  PubMed  Google Scholar 

  63. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams T, Kay AB (2002) Eotaxin and eotaxin-2 induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169:2712–2718

    CAS  PubMed  Google Scholar 

  64. Bruynzeel-Koomen CAFM, van Wichen DF, Spry CJF, Venge P, Bruynzeel PLB (1988) Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 118:229–238

    CAS  PubMed  Google Scholar 

  65. Mitchell EB, Chapman MD, Pope FM, Crow J, Jouhal SS, Platts-Mills TAE (1982) Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet I: 127–130

    Google Scholar 

  66. Walker C, Kagi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CA, Wüthrich B (1993) Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 23:145–153

    CAS  PubMed  Google Scholar 

  67. Niggemann B, Beyer K, Wahn U (1994) The role of eosinophils and eosinophil cationic protein in monitoring oral challenge tests in children with food sensitive atopic dermatitis. J Allergy Clin Immunol 94:963–971

    Article  CAS  PubMed  Google Scholar 

  68. Simon D, Braathen LR, Simon HU (2003) Eosinophils and atopic dermatitis. Allergy 59:561–570

    Google Scholar 

  69. Simon HU (1998) Eosinophil apoptosis in allergic diseases — an emerging new issue. Clin Exp Allergy 28:1321–1324

    Article  CAS  PubMed  Google Scholar 

  70. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K (1997) Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158:3902–3908

    CAS  PubMed  Google Scholar 

  71. Simon HU (2000) Eosinophil apoptosis—pathophysiologic and therapeutic implications. Allergy 55:910–915

    CAS  PubMed  Google Scholar 

  72. Simon HU, Blaser K (1995) Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 16:53–55

    Article  CAS  PubMed  Google Scholar 

  73. Shinagawa K, Trifilieff A, Anderson GP (2003) Involvement of CCR3-reactive chemokines in eosinophil survival. Int Arch Allergy Immunol 130:150–157.(2003) Involvement of CCR3-reactive chemokines in eosinophil survival. Int Arch Allergy Immunol 130:150–157

    Article  CAS  PubMed  Google Scholar 

  74. Wedi B, Raap U, Lewrick H, Kapp A (1997) Delayed eosinophil programmed cell death in vitro: a common feature in inhalant allergy and extrinsic and intrinsic dermatitis. J Allergy Clin Immunol 100:536–543

    Article  CAS  PubMed  Google Scholar 

  75. Dibbert B, Daigle I, Braun D, Schranz C, Weber M, Blaser K, Zangemeister-Wittke U, Akbar AN, Simon HU (1998) Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 92:778–783

    CAS  PubMed  Google Scholar 

  76. Ogawa K, Hashida R, Miyagawa M, Kagaya S, Sugita Y, Matsumoto K, Katsunuma T, Akasawa A, Tsujimoto G, Saito H (2003) Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils. Clin Exp Immunol 131:436–445

    CAS  PubMed  Google Scholar 

  77. Ploetz SG, Dibbert B, Abeck D, Ring J, Simon HU (1998) Bcl-2 expression by eosinophils in a patient with hypereosinophilia. J Allergy Clin Immunol 102:1037–1040

    Google Scholar 

  78. Wedi B, Raap U, Kapp A (1999) Significant delay of apoptosis and Fas resistance in eosinophils of subjects with intrinsic and extrinsic type of atopic dermatitis. Int Arch Allergy Immunol 118:234–235

    Article  CAS  PubMed  Google Scholar 

  79. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, Simon HU (1998) Disruption of Fas receptor signaling by nitric oxide in eosinophils. J Exp Med 187: 415–425

    Article  CAS  PubMed  Google Scholar 

  80. Takafuji S, Bischoff SC, de Weck AL, Dahinden CA (1991) IL-3 and IL-5 prime normal eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol 147: 3855–3861

    CAS  PubMed  Google Scholar 

  81. Rothenberg ME, Owen WF, Silberstein DS, Soberman RJ, Austen KF, Stevens RL (1987) Eosinophils cocultered with endothelial cells have increased survival and functional properties. Science 237:645–647

    CAS  PubMed  Google Scholar 

  82. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB (1992) Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952–2959

    CAS  PubMed  Google Scholar 

  83. Tomioka K, MacGlashan DW, Lichtenstein LM, Bochner BS, Schleimer RP (1993) GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. J Immunol 151:4989–4997

    CAS  PubMed  Google Scholar 

  84. Dahinden CA, Zingg J, Maly FE, de Weck AL (1988) Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5a and fMLP as second signals. J Exp Med 167: 1281–1295

    Article  CAS  PubMed  Google Scholar 

  85. Simon HU, Plötz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-Schaffer F (2003) Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells’ syndrome. Eur J Immunol 33:834–839

    Article  CAS  PubMed  Google Scholar 

  86. Simon HU, Weber M, Becker E, Zilberman Y, Blaser K, Levi-Schaffer F (2000) Eosinophils maintain their capacity to signal and release eosinophilic cationic protein upon repetitive stimulation with the same agonist. J Immunol 165:4069–4075

    CAS  PubMed  Google Scholar 

  87. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, Blaser K, Wüthrich B, Simon HU (2002) Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169:1021–1027

    CAS  PubMed  Google Scholar 

  88. Yousefi S, Hemmann S, Weber M, Hoelzer C, Hartung K, Blaser K, Simon HU (1995) IL-8 is expressed by human peripheral blood eosinophils. J Immunol 154:5481–5490

    CAS  PubMed  Google Scholar 

  89. Bochner BS (2000) Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 106:S292–302

    CAS  PubMed  Google Scholar 

  90. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:183–186

    CAS  PubMed  Google Scholar 

  91. Kita H, Kaneko M, Bartemes KR, Weiler DA, Schimming AW, Reed CE, Gleich GJ (1999) Does IgE bind to and activate eosinophils from patients with allergy? J Immunol 162:6901–6911

    CAS  PubMed  Google Scholar 

  92. Seminario MC, Saini SS, MacGlashan DW, Bochber BS (1999) Intracellular expression and release of FceRIa by human eosinophils. J Immunol 162:6893–6900

    CAS  PubMed  Google Scholar 

  93. Bandeira-Melo C, Bozza PT, Weller PF (2002) The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol 109:393–400

    CAS  PubMed  Google Scholar 

  94. Schauer U, Trube M, Jager R, Gieler U, Rieger CH (1995) Blood eosinophils, eosinophil-derived proteins, and leukotriene C4 generation in relation to bronchial hyperreactivity in children with atopic dermatitis. Allergy 50:126–132

    CAS  PubMed  Google Scholar 

  95. Sanak M, Simon HU, Szczeklik A (1997) Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350:1599–1600

    Article  CAS  PubMed  Google Scholar 

  96. Mawhorter SD, Kazura JW, Boom WH (1994) Human eosinophils as antigen-presenting cells: relative efficacy for superantigen-and antigen-induced CD4+ T-cell proliferation. Immunology 81:584–591

    CAS  PubMed  Google Scholar 

  97. Mori A, Suko M, Nishizaki Y, Kaminuma O, Matsuzaki G, Ito K, Etoh T, Nakagawa H, Tsuruoka N, Okudaira H (1994) Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporinA and glucocorticoid. Int Arch Allergy Immunol 104:S32–35

    Google Scholar 

  98. Mori A, Kaminuma O, Suko M, Inoue S, Ohmura T, Hoshino A, Asakura Y, Miyazawa K, Yokota T, Okumura Y, Ito K, Okudaira H (1997) Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89:2891–2900

    CAS  PubMed  Google Scholar 

  99. Meagher LC, Cousin JM, Seckl JR, Haslett C (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156:4422–4428

    CAS  PubMed  Google Scholar 

  100. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU (1997) Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 52:144–154

    CAS  PubMed  Google Scholar 

  101. Simon D, Conus S, Vassina E, Braathen LR, Simon HU (2003) Immunopharmacological effects of topical tacrolimus in atopic dermatitis. J Eur Acad Derm Venerol 17: S156

    Google Scholar 

  102. Breuckmann F, von Kobyletzki G, Avermaete A, Pieck C, Kreuter A, Brockmeyer NH, Altmeyer P, Gambichler T (2002) Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Eur J Med Res 7:315–322

    CAS  PubMed  Google Scholar 

  103. Simon HU (2002) The neutralization of Interleukin-5 as a therapeutic concept in allergic inflammation. Sarcoidosis Vasc Diffuse Lung Dis 19:25–28

    PubMed  Google Scholar 

  104. Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee J, Gelfand EW (1997) Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 155:819–825

    CAS  PubMed  Google Scholar 

  105. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O’Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ (2000) Effects of an interleukin-5 blocking antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356:2144–2148

    Article  CAS  PubMed  Google Scholar 

  106. Plötz SG, Simon HU, Darsow U, Simon D, Vassina E, Yousefi S, Hein R, Smith T, Behrendt H, Ring J (2003) Use of anti-interleukin-5 antibody in hypereosinophilic syndrome with eosinophilic dermatitis. N Eng J Med 349: 2332–2337

    Google Scholar 

Download references

Authors
  1. D. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Straße 29, 80802, München, Germany

    Johannes Ring

  2. Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, Frauenlobstraße 9-11, 80337, München, Germany

    Bernhard Przybilla

  3. Klinik und Poliklinik für Dermatologie, Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Germany

    Thomas Ruzicka

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Simon, D. (2006). The Role of Eosinophils in Atopic Eczema. In: Ring, J., Przybilla, B., Ruzicka, T. (eds) Handbook of Atopic Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29856-8_31

Download citation

  • DOI: https://doi.org/10.1007/3-540-29856-8_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23133-2

  • Online ISBN: 978-3-540-29856-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation